These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1433847)

  • 1. [Pulmonary reaction after protamine reversal of heparin in goats and rabbits].
    Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
    Masui; 1992 Aug; 41(8):1260-6. PubMed ID: 1433847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin].
    Montalescot G
    Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-protamine complexes cause pulmonary hypertension in goats.
    Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
    Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
    Nuttall GA; Murray MJ; Bowie EJ
    Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulation.
    Wakefield TW; Ucros I; Kresowik TF; Hinshaw DB; Stanley JC
    J Vasc Surg; 1989 Jun; 9(6):772-7. PubMed ID: 2724464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
    Nathan N; Aissa J; Benveniste J; Arnoux B
    Eur J Anaesthesiol; 1992 Jul; 9(4):347-52. PubMed ID: 1628640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging the ovine heparin-protamine interaction with 111In-protamine.
    Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM
    J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of complement-mediated events after protamine reversal of heparin anticoagulation.
    Wakefield TW; Kirsh MM; Till GO; Brothers TE; Hantler CB; Stanley JC
    J Surg Res; 1991 Jul; 51(1):72-6. PubMed ID: 2067362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
    Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
    Dehmer GJ; Lange RA; Tate DA; Pirwitz M; Daniel W; Fisher M; Bonnem EM
    Circulation; 1996 Nov; 94(9 Suppl):II347-52. PubMed ID: 8901773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
    Hobbhahn J; Conzen PF; Zenker B; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
    Kurrek MM; Winkler M; Robinson DR; Zapol WM
    Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
    Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
    Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulation.
    Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Tejwani S; Hulin MS; Stanley JC
    J Surg Res; 1996 Jun; 63(1):280-6. PubMed ID: 8661211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.